Roivant Sciences Ltd
NASDAQ:ROIV
Roivant Sciences Ltd
NASDAQ:ROIV
Price:
11.43 USD
-0.61%
Updated:
May 16, 2024
Balance Sheet
Balance Sheet Decomposition
Roivant Sciences Ltd
Roivant Sciences Ltd
| Current Assets | 6.8B |
| Cash & Short-Term Investments | 6.7B |
| Receivables | 44.3m |
| Other Current Assets | 91.6m |
| Non-Current Assets | 505.9m |
| Long-Term Investments | 239.9m |
| PP&E | 68.8m |
| Intangibles | 150.4m |
| Other Non-Current Assets | 46.8m |
| Current Liabilities | 244.9m |
| Accounts Payable | 35.2m |
| Accrued Liabilities | 132.6m |
| Other Current Liabilities | 77m |
| Non-Current Liabilities | 978m |
| Long-Term Debt | 403.3m |
| Other Non-Current Liabilities | 574.7m |
Balance Sheet
Roivant Sciences Ltd
Roivant Sciences Ltd
Currency: USD
| Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
2 183
|
2 055
|
2 060
|
1 677
|
|
| Cash Equivalents |
2 183
|
2 055
|
2 060
|
1 677
|
|
| Total Receivables |
15
|
14
|
0
|
33
|
|
| Accounts Receivables |
9
|
11
|
0
|
30
|
|
| Other Receivables |
7
|
3
|
0
|
2
|
|
| Inventory |
0
|
0
|
0
|
3
|
|
| Other Current Assets |
21
|
118
|
86
|
86
|
|
| Total Current Assets |
2 219
|
2 187
|
2 147
|
1 799
|
|
| PP&E Net |
74
|
77
|
87
|
92
|
|
| Intangible Assets |
0
|
0
|
0
|
145
|
|
| Long-Term Investments |
93
|
290
|
326
|
304
|
|
| Other Long-Term Assets |
90
|
36
|
26
|
50
|
|
| Total Assets |
2 477
N/A
|
2 590
+5%
|
2 585
0%
|
2 390
-8%
|
|
| Liabilities | |||||
| Accounts Payable |
10
|
21
|
35
|
38
|
|
| Accrued Liabilities |
77
|
89
|
139
|
179
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
43
|
|
| Other Current Liabilities |
5
|
109
|
11
|
13
|
|
| Total Current Liabilities |
92
|
219
|
184
|
272
|
|
| Long-Term Debt |
109
|
170
|
210
|
379
|
|
| Minority Interest |
77
|
264
|
405
|
450
|
|
| Other Liabilities |
168
|
138
|
129
|
131
|
|
| Total Liabilities |
445
N/A
|
792
+78%
|
928
+17%
|
1 232
+33%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1 109
|
1 919
|
2 764
|
3 773
|
|
| Additional Paid In Capital |
3 144
|
3 815
|
4 422
|
4 933
|
|
| Other Equity |
2
|
99
|
1
|
3
|
|
| Total Equity |
2 032
N/A
|
1 798
-12%
|
1 657
-8%
|
1 158
-30%
|
|
| Total Liabilities & Equity |
2 477
N/A
|
2 590
+5%
|
2 585
0%
|
2 390
-8%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
685
|
685
|
695
|
760
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
